药物科学研究院高端药物制剂与材料研究中心学术报告

药物科学研究院

高端药物制剂与材料研究中心学术报告

报告题目：Target Delivery of Biologics (part II)

报告时间：2023年8月30日（星期三）下午14:30

报告会场：中国药科大学江宁校区学院实验楼一期1楼122报告厅

报  告 人： 高虓虎  教  授

主  持 人： 张   灿  教  授

报告人简介

Dr. Gao received his Ph.D. degree in chemistry from Indiana University, Bloomington in 2004, and his postdoctoral training from the Department of Biomedical Engineering at Georgia Tech and the Winship Cancer Institute at Emory University. He became a faculty member in the Department of Bioengineering and the Center for Nanotechnology at the University of Washington, Seattle in 2005. His research interests include cancer nanotechnology, molecular engineering, molecular imaging, and drug delivery.

报告摘要

Biomacromolecule-based imaging agents and therapeutics such as DNA, RNA, and proteins are often superior in structural and functional diversity compared to small molecules and are easier to design or screen. Despite these fundamental advantages, the power and impact of biomacromolecule-based agents are often undermined by the delivery challenge. Previously we designed natural protein-based delivery vehicles that solved the problem of excessive cationic charges often seen in delivery technologies. In this talk, I will discuss the challenges we encountered in the past 4 years and the directions we are taking to address these issues with the ultimate goal of translation.

高端药物制剂与材料研究中心

中国药科大学药物科学研究院

多靶标天然药物全国重点实验室